Back to Top
Go Back
Journal Photo for American Heart Journal
Peer reviewed only Open Access

American Heart Journal (AHJ)

Publisher : Elsevier
Medicine Cardiology Cardiovascular Medicine
Claim Your Journal Get PRC Visit Website
e-ISSN 1097-6744
p-ISSN 0002-8703
Issue Frequency Monthly
Impact Factor 4.8
Est. Year 1925
Mobile 9378656800
Language English
APC YES
Impact Factor Assignee Google Scholar
Email usinfo@sciencedirect.com

Journal Descriptions

The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.

American Heart Journal (AHJ) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Medicine, Cardiology, Cardiovascular Medicine , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0002-8703, E-ISSN: 1097-6744, Established: 1925, Impact Factor: 4.8
  • Does Not Provide Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Role In Research Journal

C. Noel Bairey Merz Profile Photo
C. Noel Bairey Merz
Editorial Board Member

Publications of AHJ

Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: Incidence and risk factors
Emelia J. Benjamin June, 2013
Background Newly diagnosed atrial fibrillation (AF) during severe sepsis is associated with increased risks of in-hospital stroke and mortality. However, the prevalence, incidence, and risk...
Galectin 3 and incident atrial fibrillation in the community
Emelia J. Benjamin May, 2014
Background Galectin 3 (Gal-3) is a potential mediator of cardiac fibrosis, and Gal-3 concentrations predict incident heart failure. The same mechanisms that lead to cardiac fibrosis in hear...
Cardiovascular stress response and coronary artery disease: Evidence of an adverse postmenopausal effect in women
C. Noel Bairey Merz May, 1998
Objectives To test the hypothesis that postmenopausal women demonstrate greater vascular instability, measured by enhanced cardiovascular stress responses during mental stress, compared with...
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: ...
C. Noel Bairey Merz June, 2010
Background Compared with men, women have more evidence of myocardial ischemia with no obstructive coronary artery disease. Although low endogenous estrogen levels are associated with endoth...
Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol
C. Noel Bairey Merz September, 2017
Background Recent data from the National Cardiovascular Data Registry indicate that women with ST-segment-elevation myocardial infarction (STEMI) continue to have higher mortality and repor...
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
C. Noel Bairey Merz June, 2004
Background The cardiovascular risk reduction observed in many trials of lipid-lowering agents is greater than expected on the basis of observed low-density lipoprotein cholesterol (LDL-C) l...
Triggers of angina and ST-segment depression in ambulatory patients with coronary artery disease: Evidence for an uncoupling of angina and ischemia
C. Noel Bairey Merz October, 1994
This study evaluated daily-life physical and mental triggers of painful and painless myocardial ischemia and of anginal pain in patients with coronary artery disease (CAD) by using ambulator...
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial
C. Noel Bairey Merz July, 2021
Background Approximately half of all women with anginal symptoms and/or signs of ischemia and no obstructive coronary artery disease (INOCA) referred for coronary angiography have elevated ...
Global inflammation predicts cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) studyq
C. Noel Bairey Merz November, 2005
Background Measurement of C-reactive protein (CRP), a marker of inflammation, is recommended to improve cardiovascular disease (CVD) risk stratification. However, no studies have collective...
Large brachial artery diameter is associated with angiographic coronary artery disease in women
C. Noel Bairey Merz May, 2002
Background: Noninvasive methods are needed for the identification of women at highest risk for coronary artery disease (CAD) who might benefit most from aggressive preventive therapy. Identi...